TRAW's three largest insider shareholders as of September 29, 2026 are Advisors Llc Orbimed (TenPercentOwner, 1.20Mn shares), Iain D. Dukes (Chief Executive Officer, 171.13K shares), Nikolay Savchuk (Chief Operating Officer, 150.61K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Advisors Llc Orbimed | TenPercentOwner | 0 | 1,203,250 | 1,203,250 | 63.8% | 28 Apr, 2026 |
| 2 | Iain D. Dukes | Chief Executive Officer | 171,130 | 0 | 171,130 | 9.1% | 16 Dec, 2025 |
| 3 | Nikolay Savchuk | Chief Operating Officer | 150,606 | 0 | 150,606 | 8.0% | 16 Dec, 2025 |
| 4 | Charles David Pauza | Chief Science Officer Virology | 115,971 | 0 | 115,971 | 6.1% | 16 Dec, 2025 |
| 5 | Robert Redfield | Chief Medical Officer | 113,919 | 0 | 113,919 | 6.0% | 16 Dec, 2025 |
| 6 | Werner Cautreels | Chief Executive Officer | 109,222 | 0 | 109,222 | 5.8% | 16 Dec, 2025 |
| 7 | Mary Teresa Shoemaker | Director | 6,292 | 0 | 6,292 | 0.3% | 16 Dec, 2025 |
| 8 | Jack E Stover | Director | 6,165 | 0 | 6,165 | 0.3% | 16 Dec, 2025 |
| 9 | Trafford Clarke | Director | 6,157 | 0 | 6,157 | 0.3% | 16 Dec, 2025 |
| 10 | John Harold Leaman | Director | 4,058 | 0 | 4,058 | 0.2% | 16 Dec, 2025 |
| 11 | Steven M Fruchtman | President, Chief Executive Off | 1 | 0 | 1 | 0.0% | 15 Mar, 2024 |
| 12 | Abraham N. Oler | Svp Corp Dev Gen Counsel | 1 | 0 | 1 | 0.0% | 31 Jan, 2022 |
| 13 | Mark Patrick Guerin | Cfo | 1 | 0 | 1 | 0.0% | 20 Jun, 2024 |
| 14 | Mark S. Md Gelder | Chief Medical Officer | 0 | 0 | 0 | 0.0% | 08 Feb, 2023 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 09 Jul, 2026 | Nikolay Savchuk | Chief Operating Officer | Acquired A | 93,000 | $0.00 | $0 | 93,000 | Direct |
| 09 Jul, 2026 | Charles David Pauza | Chief Science Officer Virology | Acquired A | 97,000 | $0.00 | $0 | 97,000 | Direct |
| 09 Jul, 2026 | Jack E Stover | Director | Acquired A | 14,150 | $0.00 | $0 | 14,150 | Direct |
| 09 Jul, 2026 | Iain D. Dukes | Chief Executive Officer | Acquired A | 274,000 | $0.00 | $0 | 274,000 | Direct |
| 09 Jul, 2026 | John Harold Leaman | Director | Acquired A | 14,150 | $0.00 | $0 | 14,150 | Direct |
| 09 Jul, 2026 | Werner Cautreels | Director | Acquired A | 14,150 | $0.00 | $0 | 14,150 | Direct |
| 09 Jul, 2026 | Mary Teresa Shoemaker | Director | Acquired A | 14,150 | $0.00 | $0 | 14,150 | Direct |
| 09 Jul, 2026 | Trafford Clarke | Director | Acquired A | 14,150 | $0.00 | $0 | 14,150 | Direct |
| 09 Jul, 2026 | Robert Redfield | Chief Medical Officer | Acquired A | 84,000 | $0.00 | $0 | 84,000 | Direct |
| 09 Jul, 2026 | Charles Nolan Parker | Chief Financial Officer | Acquired A | 90,000 | $0.00 | $0 | 90,000 | Direct |
| 16 Apr, 2026 | Advisors Llc Orbimed | TenPercentOwner | Acquired P | 597,729 | $1.67 | $998.21K | 1,203,250 | Indirect |
| 16 Apr, 2026 | Advisors Llc Orbimed | TenPercentOwner | Acquired P | 597,729 | — | — | 597,729 | Indirect |
| 16 Apr, 2026 | Advisors Llc Orbimed | TenPercentOwner | Acquired P | 597,729 | — | — | 597,729 | Indirect |
| 16 Apr, 2026 | Advisors Llc Orbimed | TenPercentOwner | Acquired P | 1,793,187 | — | — | 1,793,187 | Indirect |
| 08 Mar, 2026 | Trafford Clarke | Director | Acquired A | 33,435 | $0.00 | $0 | 33,435 | Direct |
| 08 Mar, 2026 | Mary Teresa Shoemaker | Director | Acquired A | 33,435 | $0.00 | $0 | 33,435 | Direct |
| 08 Mar, 2026 | Iain D. Dukes | Chief Executive Officer | Acquired A | 231,336 | $0.00 | $0 | 231,336 | Direct |
| 08 Mar, 2026 | John Harold Leaman | Director | Acquired A | 33,435 | $0.00 | $0 | 33,435 | Direct |
| 08 Mar, 2026 | Werner Cautreels | Director | Acquired A | 31,258 | $0.00 | $0 | 31,258 | Direct |
| 08 Mar, 2026 | Jack E Stover | Director | Acquired A | 33,435 | $0.00 | $0 | 33,435 | Direct |